HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Alejandro Aris Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Aris, A. Articles by Saura, E. Search for Related Content PubMed PubMed Citation Articles by Aris, A. Articles by Saura, E.

Ann Thorac Surg 1993;55:1104-1108
© 1993 The Society of Thoracic Surgeons

---

Articles

Cardiopulmonary bypass in HIV-positive patients

Departments of Cardiac Surgery, Hospital de la Santa Creu i Sant Pau, Hospital Clinic i Provincial, and Hospital de Bellvitge, Barcelona, Spain

^_* Address reprint requests to Dr Aris, Cardiac Surgery Unit, Hospital de la Santa Creu i Sant Pau, Avenida San A. M. Claret 167, 08025 Barcelona, Spain.

To prove the hypothesis that cardiopulmonary bypass may accelerate the development of acquired immunodeficiency syndrome (AIDS) in the human immunodeficiency virus carrier, the clinical course of 40 patients positive for human immunodeficiency virus who underwent cardiac operations between 1986 and 1992 was analyzed, especially in regard to the progression to AIDS. Mean age was 30 years (range, 19 to 61 years) Thirty-four patients (85%) were intravenous drug abusers; in 4 (10%) transmission of infection was sexual, and in 2 (5%) it was through a contaminated blood transfusion. Valve procedures were performed in 38 patients (95%), mostly for endocarditis in drug addicts. Hospital mortality was 20% (8 patients). The 32 survivors have been followed up a mean of 21 months (range, 4 months to 6 years). Four patients (12.5%) experienced progression to AIDS during the follow-up period. Actuarial progression to AIDS is 5%, (±5%) at 1 year, 20% (±10%) at 2 years, and 40% (±19%) at 5 years. There have been 8 late deaths (5 due to recurrent endocarditis, 2 due to AIDS, and 1 due to overdose). Actuarial survival is 79% (±8%) at 1 year, 60% (±11%) at 2 years, and 48% (±14%) at 5 years. The results indicate that progression to AIDS in the patient positive for human immunodeficiency virus is not accelerated by the use of cardiopulmonary bypass. The poor prognosis in these patients is mainly related to the particular pathological conditions that often affect the drug addict population.

This article has been cited by other articles:

				Endorsed by the European Society of Clinical Micro, Authors/Task Force Members, G. Habib, B. Hoen, P. Tornos, F. Thuny, B. Prendergast, I. Vilacosta, P. Moreillon, M. de Jesus Antunes, et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): The Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC) Eur. Heart J., October 1, 2009; 30(19): 2369 - 2413. [Full Text] [PDF]

				F. Filsoufi, S. P. Salzberg, K. T. J. Harbou von, E. Neibart, and D. H. Adams Excellent Outcomes of Cardiac Surgery in Patients Infected with HIV in the Current Era Clinical Infectious Diseases, August 15, 2006; 43(4): 532 - 536. [Abstract] [Full Text] [PDF]

				C.-A. Mestres, J. E. Chuquiure, X. Claramonte, J. Munoz, N. Benito, M. A. Castro, J. L. Pomar, and J. M. Miro Long-term results after cardiac surgery in patients infected with the human immunodeficiency virus type-1 (HIV-1) Eur J Cardiothorac Surg, June 1, 2003; 23(6): 1007 - 1016. [Abstract] [Full Text] [PDF]

				V. L. Mahan, J. M. Balaguer, A. T. Pezzella, T. J. V. Salm, and B. J. Mady Successful coronary artery bypass surgery in a patient with AIDS Ann. Thorac. Surg., November 1, 2000; 70(5): 1698 - 1699. [Abstract] [Full Text] [PDF]